Press Release 1999

Press Release 1999

The benefits of dietary fiber are well known, and the less digestible a fiber is, the more effective it is. Fenufibers , Sabinsa Corporation's proprietary fiber preparation made from fenugreek seeds (Trigonella foenum graecum), was recently shown to be less digestible than other popular fibers.

The study was performed at the University of Georgia, and compared the performance of Fenufibers in the GI (gastrointestinal) tract with wheat bran and oat bran. Fenufibers digestibility was shown to be minimal when compared to those popular sources of fiber.

A copy of the abstract is available by contacting Sabinsa Corporation at either 121 Ethel Road West, Unit 6, Piscataway, NJ 08854 or at 594 South American Way, Payson, Utah 84651.

Sabinsa Corporation, which has pioneered the introduction of several Ayurvedic herbal extracts in the US market, is an application oriented manufacturing and marketing company which manufacturers Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff.

For more Information:
Todd Norton
(801)-465-8400

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.